Estimated Impacts of Rotavirus Vaccine Recommendation Changes in the U.S.
Asare, E.; Kwon, J.; Chitwood, M. H.; Perniciaro, S.; Gonsalves, G. S.; Pitzer, V. E.
Show abstract
In January 2026, the United States Department of Health and Human Services downgraded the recommendation for infant immunization with rotavirus vaccine to one of shared clinical decision-making. We use a validated model for the transmission dynamics of rotavirus to predict the magnitude and timing of increases in the number of rotavirus hospitalizations in the US and in representative states given possible decreases in vaccine coverage. Rotavirus hospitalizations are likely to increase within two to three years following a drop in vaccine coverage, resulting in over 200,000 hospitalizations between July 2026-June 2031 if coverage were to drop to 20%. The burden is likely to fall disproportionately on southern states that currently experience higher rates of rotavirus hospitalization.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada 94%
- Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level 93%
- Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use 91%
Similar papers in this journal
- Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection 92%
- Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers 91%
- Large-scale genomic analysis of SARS-CoV-2 Omicron BA.5 emergence in the United States 90%
Similar papers in this journal
- Epidemiological dynamics of enterovirus D68 in the US: implications for acute flaccid myelitis 91%
- Persistence of SARS-CoV-2 immunity, Omicron’s footprints, and projections of epidemic resurgences in South African population cohorts 91%
- SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster 90%
Similar papers in this journal
- Informing pandemic response in the face of uncertainty. An evaluation of the U.S. COVID-19 Scenario Modeling Hub 93%
- Maternal pertussis immunization and the blunting of routine vaccine effectiveness: A meta-analysis and modeling study 92%
- Modeling serological testing to inform relaxation of social distancing for COVID-19 control 92%
Similar papers in this journal
- Burden of lower respiratory tract infections preventable by adult immunization with 15- and 20-valent pneumococcal conjugate vaccines in the United States 93%
- Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 92%
- The impact of vaccination on COVID-19 outbreaks in the United States 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.